| 000 | 01411 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513094017.0 | ||
| 264 | 0 | _c19961021 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.1996.713893000.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNeri, M | |
| 245 | 0 | 0 |
_aGastric mucosal infiltration by Helicobacter pylori favours bacterial survival after treatment. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cApr 1996 |
||
| 300 |
_a181-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnti-Bacterial Agents |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastric Mucosa _xmicrobiology |
| 650 | 0 | 4 |
_aHelicobacter Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSusi, D | |
| 700 | 1 | _aBovani, I | |
| 700 | 1 | _aLaterza, F | |
| 700 | 1 | _aPorreca, E | |
| 700 | 1 | _aCuccurullo, F | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 10 _gno. 2 _gp. 181-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.1996.713893000.x _zAvailable from publisher's website |
| 999 |
_c8727328 _d8727328 |
||